New Zealand Neurosurgeon Successfully Tests New Brain Cancer Vaccine

New Zealand neurosurgeon Martin Hunn, MD, of Wellington Hospital has successfully tested a new vaccine for aggressive brain cancer on mice that stimulates the immune system to attack tumors and will help develop a vaccine for people with glioblastoma multiforme (GBM) in the future.

According to study results that appear in the Clinical Cancer Research journal, the vaccine — containing tumor cells and an immune-boosting agent derived from marine sponges — was strong enough to kill glioma tumors in mice. For more information, click here to read the full release.